Since the “microbiota revolution”, the human intestinal microbiota has been considered a major contributor to the control of key physiological functions of the host. Its role is crucial, especially in the barrier function of the gut and the maturation of the immune system. The first studies that showed a “dysbiosis” of the intestinal
microbiota and identified pathological signatures have raised great interest, not only among scientists but also among health industrialists.

Subsequent studies, conducted most often in animal models, have demonstrated a contributing role of the microbiota in various diseases. This new science suggested the existence of a new diagnostic means, made it possible to define new intervention strategies targeting the microbiota, and even saw in microorganisms a new source of treatments for various diseases, such as microbiota transplantation, new generation probiotics or bacterial metabolites.

Author
Dr. Hervé BLOTTIERE
Author
Dr. Hervé BLOTTIERE
Category
Immunology
Publication type
Proceedings
Year
2018
Download the publication